Furthermore, a significant increase in alpha-ketoglutarate, a tumor metabolite, supported the activities of histone lysine demethylases and favored the emergence of dedifferentiated BRAF inhibitor-resistant subpopulations (107). The gene discussed is BRAF; the disease is neoplasm.